Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;67(8):1727-1734.
doi: 10.1007/s10840-024-01876-x. Epub 2024 Jul 15.

Safety and feasibility of pulmonary vein isolation utilizing pulsed field ablation in patients with symptomatic atrial fibrillation and implanted Watchman devices

Ivana Garza  1 , Haider Al Taii  2 , Arun Narayanan  2 , Hani Jneid  1 , Dean Sabayon  3
Affiliations

Safety and feasibility of pulmonary vein isolation utilizing pulsed field ablation in patients with symptomatic atrial fibrillation and implanted Watchman devices

Ivana Garza et al. J Interv Card Electrophysiol. 2024 Nov.

Abstract

Background: Pulsed field ablation (PFA) is a novel method of non-thermal cardiac ablation for atrial fibrillation (AF). Its use on patients with pre-existing Watchman devices has not been studied.

Methods: Pulmonary vein isolation (PVI) utilizing PFA was performed in 7 patients with symptomatic AF and implanted Watchman devices. All cases were conducted at a single academic center.

Results: Successful PVI in patients with Watchman devices implanted at a median time of 534 days prior to the index ablation procedure (IQR 365 days) was achieved in all cases. No major adverse events (intraprocedural CVA, post-procedural CVA, major or minor bleeding events, device embolization, or cardiac tamponade) were observed. In 6 of 7 patients, a low-dose direct oral anticoagulant (DOAC) strategy was implemented post-PFA.

Conclusion: We present the first reported case series of PFA in patients with AF and implanted Watchman devices. This study highlights the safety and feasibility of the FARAPULSE PFA system in this patient population.

Keywords: Left atrial appendage closure device; Pulmonary vein isolation; Pulse field ablation.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Similar articles

See all similar articles

Cited by

References

    1. Reddy VY, Gerstenfeld EP, Natale A, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023;389(18):1660–71. https://doi.org/10.1056/NEJMoa2307291 . - DOI - PubMed
    1. Aldaas OM, Malladi C, Han FT, et al. Pulsed field ablation versus thermal energy ablation for atrial fibrillation: a systematic review and meta-analysis of procedural efficiency, safety, and efficacy. J Interv Card Electrophysiol. 2024;67:639–48. - DOI - PubMed
    1. Ruwald MH, Johannessen A. Hansen ML et al Pulsed field ablation in real-world atrial fibrillation patients: clinical recurrence, operator learning curve and re-do procedural findings. J Interv Card Electrophysiol. 2023;66:1837–48. - DOI - PubMed
    1. Turagam MK, Lavu M, Afzal MR, et al. Catheter ablation for atrial fibrillation in patients with Watchman left atrial appendage occlusion device: results from a multicenter registry. J Cardiovasc Electrophysiol. 2017;28(2):139–46. - DOI - PubMed
    1. Turagam MK, Neuzil P, Schmidt B, et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF Registry. Circulation. 2023;148(1):35–46. - DOI - PubMed

LinkOut - more resources